Johnson & Johnson
(JNJ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,409,000 | 16,323,000 | 13,831,000 | 10,514,000 | 9,672,000 |
| Depreciation Amortization | 3,746,000 | 3,895,000 | 4,104,000 | 3,666,000 | 3,158,000 |
| Income taxes - deferred | -270,000 | 441,000 | -607,000 | -39,000 | -836,000 |
| Accounts receivable | -415,000 | -275,000 | -763,000 | 83,000 | -883,000 |
| Other Working Capital | 1,647,000 | -855,000 | -959,000 | -969,000 | 1,523,000 |
| Other Operating Activity | -548,000 | -819,000 | 1,808,000 | 2,141,000 | 1,664,000 |
| Operating Cash Flow | $19,569,000 | $18,710,000 | $17,414,000 | $15,396,000 | $14,298,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,000 | 917,000 | -3,137,000 | -1,425,000 | -1,551,000 |
| Net Acquisitions | -954,000 | -2,129,000 | -835,000 | -4,486,000 | -2,797,000 |
| Purchase Of Investment | -40,828,000 | -34,913,000 | -18,923,000 | -13,434,000 | -29,882,000 |
| Sale Of Investment | 34,149,000 | 24,119,000 | 18,058,000 | 14,797,000 | 30,396,000 |
| Other Investing Activity | -103,000 | -299,000 | -266,000 | 38,000 | -778,000 |
| Investing Cash Flow | $-7,735,000 | $-12,305,000 | $-5,103,000 | $-4,510,000 | $-4,612,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,416,000 | 1,863,000 | 1,411,000 | 3,268,000 | 9,729,000 |
| Debt Issued | 75,000 | 2,098,000 | 3,607,000 | 45,000 | 4,470,000 |
| Debt Repayment | -68,000 | -1,844,000 | -1,593,000 | -804,000 | -16,000 |
| Common Stock Issued | 1,005,000 | 1,543,000 | 2,649,000 | 2,720,000 | 1,246,000 |
| Common Stock Repurchased | -5,290,000 | -7,124,000 | -3,538,000 | -12,919,000 | -2,525,000 |
| Dividend Paid | -8,173,000 | -7,768,000 | -7,286,000 | -6,614,000 | -6,156,000 |
| Other Financing Activity | -1,101,000 | -1,267,000 | -1,341,000 | -6,258,000 | -11,200,000 |
| Financing Cash Flow | $-11,136,000 | $-12,499,000 | $-6,091,000 | $-20,562,000 | $-4,452,000 |
| Exchange Rate Effect | -1,489,000 | -310,000 | -204,000 | 45,000 | -47,000 |
| Beginning Cash Position | 14,523,000 | 20,927,000 | 14,911,000 | 24,542,000 | 19,355,000 |
| End Cash Position | 13,732,000 | 14,523,000 | 20,927,000 | 14,911,000 | 24,542,000 |
| Net Cash Flow | $-791,000 | $-6,404,000 | $6,016,000 | $-9,631,000 | $5,187,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 19,569,000 | 18,710,000 | 17,414,000 | 15,396,000 | 14,298,000 |
| Capital Expenditure | -3,463,000 | -3,714,000 | -3,595,000 | -2,934,000 | -2,893,000 |
| Free Cash Flow | 16,106,000 | 14,996,000 | 13,819,000 | 12,462,000 | 11,405,000 |